As expected, the difference of PBC screen, gp210 and sp100 between the two groups of AMA-IIF positive and AMA IIF-negative PBC patients was statistically significant, p<0.05 (Table 1). This evidence concerns the gene NUP210 and primary biliary cholangitis.